Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ES Cell International
Singapore, Singapore
- Ownership
- Public · LCTX
- Development stage
- Other
01
Overview
ES Cell International is a Singapore-based pioneer in human embryonic stem cell (hES) technology, with a focus on developing clinical-grade hES cell lines for regenerative medicine. Its platform technology enables the generation of clinical-grade master cell banks and downstream differentiation into tissues such as retinal pigment epithelium, pancreatic progenitors, and cardiomyocytes. The company’s hES cell lines (e.g., ESI-014, ESI-017) are notable for being produced under cGMP standards, with two lines (ESI-014, ESI-017) approved by the NIH for federally funded research in the US[1][4]. However, most therapeutic developments remain in the preclinical phase.
- Therapeutic areas
- EndocrinologyCardiovascularNeurologyRheumatologyGastroenterologyOphthalmology
- Modalities
- Cell therapyStem cell therapy
- Industry
- Biotech
02
Partnerships
Sydney IVF (in vitro fertilization and derivation of clinical-grade hES cell lines)California Institute for Regenerative Medicine (CIRM) (supply of research-grade hES cells)University of California (collaborations for research use of hES cells)
Beyond the preview
Go deeper on ES Cell International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ES Cell International.